1 – 47 of 47
- show: 250
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2016
-
Mark
15-year follow-up of the Second Nordic Mantle Cell Lymphoma trial (MCL2) : Prolonged remissions without survival plateau
(
- Contribution to journal › Article
- 2014
-
Mark
Deregulation of COMMD1 Is Associated with Poor Prognosis in Diffuse Large B-cell Lymphoma.
(
- Contribution to journal › Article
-
Mark
High-Dose Chemotherapy with Stem Cell Rescue in the Primary Treatment of Metastatic and Pelvic Osteosarcoma: Final Results of the ISG/SSG II Study
(
- Contribution to journal › Article
-
Mark
Risk Factors for Gastrointestinal Stromal Tumor Recurrence in Patients Treated With Adjuvant Imatinib
(
- Contribution to journal › Article
-
Mark
Gastrointestinal Stromal Tumor: A Method for Optimizing the Timing of CT Scans in the Follow-up of Cancer Patients.
(
- Contribution to journal › Article
- 2013
-
Mark
Dose-densified chemoimmunotherapy followed by systemic central nervous system prophylaxis for younger high-risk diffuse large B-cell/follicular grade 3 lymphoma patients: results of a phase II Nordic Lymphoma Group study
(
- Contribution to journal › Article
-
Mark
Benefits and Adverse Events in Younger Versus Older Patients Receiving Neoadjuvant Chemotherapy for Osteosarcoma: Findings From a Meta-Analysis.
(
- Contribution to journal › Article
- 2012
-
Mark
One vs Three Years of Adjuvant Imatinib for Operable Gastrointestinal Stromal Tumor : A Randomized Trial
(
- Contribution to journal › Article
-
Mark
Adjuvant therapy in primary GIST: state-of-the-art
(
- Contribution to journal › Scientific review
-
Mark
Primary metastatic Ewing's family tumors: results of the Italian Sarcoma Group and Scandinavian Sarcoma Group ISG/SSG IV Study including myeloablative chemotherapy and total-lung irradiation
(
- Contribution to journal › Article
-
Mark
Nordic MCL2 trial update: six-year follow-up after intensive immunochemotherapy for untreated mantle cell lymphoma followed by BEAM or BEAC plus autologous stem-cell support: still very long survival but late relapses do occur
(
- Contribution to journal › Article
-
Mark
Occupational exposure to endocrine-disrupting chemicals and the risk of uveal melanoma
(
- Contribution to journal › Article
-
Mark
High serum vascular endothelial growth factor level is an adverse prognostic factor for high-risk diffuse large B-cell lymphoma patients treated with dose-dense chemoimmunotherapy
(
- Contribution to journal › Article
-
Mark
Pesticide exposure in farming and forestry and the risk of uveal melanoma
(
- Contribution to journal › Article
- 2011
-
Mark
Nordic MCL2 Trial of 1St-Line Intensive Immunochemotherapy and Autologous Stem Cell Transplantation in Mantle Cell Lymphoma: Still Encouraging Results After Median 5½ Years Observation Time
2011) Annual Meeting of the American-Society-for-Blood-and-Marrow-Transplantation(BMT) Tandem In Biology of Blood and Marrow Transplantation 17(2). p.196-196(
- Contribution to journal › Published meeting abstract
-
Mark
Five-year Results From A Scandinavian Sarcoma Group Study (SSG XIII) Of Adjuvant Chemotherapy Combined With Accelerated Radiotherapy In High-Risk Soft Tissue Sarcoma Of Extremities And Trunk Wall
(
- Contribution to journal › Article
- 2010
-
Mark
Occupation and occupational exposure to endocrine disrupting chemicals in male breast cancer: a case-control study in Europe
(
- Contribution to journal › Article
-
Mark
Occupational exposure to electromagnetic fields and sex-differential risk of uveal melanoma
(
- Contribution to journal › Article
-
Mark
Hormonal exposures and the risk of uveal melanoma
(
- Contribution to journal › Article
-
Mark
Exon Based Transcriptome Profiling Reveals Genes That Have Prognostic Impact on the Survival of Young High Risk Diffuse Large B Cell/Follicular Grade 3 Lymphoma Patients Treated with Dose Dense Chemoimmuno therapy and CNS Prophylaxis Results From a Nordic Lymphoma Group Phase II Study
(
- Contribution to journal › Published meeting abstract
-
Mark
The Mantle Cell Lymphoma International Prognostic Index (MIPI) is superior to the International Prognostic Index (IPI) in predicting survival following intensive first-line immunochemotherapy and autologous stem cell transplantation (ASCT)
(
- Contribution to journal › Article
-
Mark
High Serum Vascular Endothelial Growth Factor (VEGF) Level Is An Adverse Prognostic Factor In High Risk Diffuse Large B Cell Lymphoma (DLBCL) Patients Treated with Dose Dense Chemoimmunotherapy and Systemic CNS Prophylaxis Results From a Nordic Phase II Study
(
- Contribution to journal › Published meeting abstract
-
Mark
Histology-driven chemotherapy of soft-tissue sarcoma.
(
- Chapter in Book/Report/Conference proceeding › Paper in conference proceeding
- 2009
-
Mark
A European treatment protocol for bone sarcoma in patients older than 40 years
2009) 45th Annual Meeting of the American-Society-of-Clinical-Oncology In Journal of Clinical Oncology 27(15).(
- Contribution to journal › Published meeting abstract
-
Mark
Adjuvant systemic therapy of gastrointestinal stromal tumors The Scandinavian Sarcoma Group perspective
(
- Contribution to journal › Article
-
Mark
Concentrations of organohalogen compounds and titres of antibodies to Epstein-Barr virus antigens and the risk for non-Hodgkin lymphoma
(
- Contribution to journal › Article
-
Mark
Sarcomas With Spindle Cell Morphology
(
- Chapter in Book/Report/Conference proceeding › Paper in conference proceeding
-
Mark
Treatment of soft tissue sarcoma of the extremity and trunk wall The Scandinavian Sarcoma Group perspective
(
- Contribution to journal › Article
-
Mark
Pre-Emptive Treatment With Rituximab of Molecular Relapse After Autologous Stem Cell Transplantation in Mantle Cell Lymphoma.
(
- Contribution to journal › Article
- 2008
-
Mark
R-CHOEP-14 X 6 Followed by Systemic CNS Prophylaxis for Diffuse Large B-Cell Lymphoma (DLBCL)/Follicular Lymphoma (FL) Grade 3 with Age Adjusted IPI Score 2-3: Preliminary Results of a Nordic Lymphoma Group (NLG) Phase 2 Study Including 160 Patients Aged 18-64 Years.
(
- Contribution to journal › Published meeting abstract
-
Mark
Long-term progression-free survival of mantle cell lymphoma after intensive front-line immunochemotherapy with in vivo-purged stem cell rescue: a nonrandomized phase 2 multicenter study by the Nordic Lymphoma Group
(
- Contribution to journal › Article
-
Mark
Pesticide exposure as risk factor for non-Hodgkin lymphoma including histopathological subgroup analysis.
(
- Contribution to journal › Article
- 2006
-
Mark
Occupational factors and risk of adult bone sarcomas: A multicentric case-control study in Europe
(
- Contribution to journal › Article
-
Mark
In utero exposure to persistent organic pollutants in relation to testicular cancer risk
(
- Contribution to journal › Article
- 2005
-
Mark
Occupational risks for uveal melanoma results from a case-control study in nine European countries
(
- Contribution to journal › Article
-
Mark
European multi-centre case-control study on risk factors for rare cancers of unknown aetiology
(
- Contribution to journal › Article
-
Mark
Use of cellular or cordless telephones and the risk for non-Hodgkin's lymphoma
(
- Contribution to journal › Article
- 2004
-
Mark
Testicular cancer and occupational exposure to polyvinyl chloride plastics: A case-control study
(
- Contribution to journal › Article
-
Mark
Concentrations of polychlorinated biphenyls in blood and the risk for testicular cancer
(
- Contribution to journal › Article
-
Mark
"Increased concentrations of polychlorinated biphenyls, hexachlorobenzenes, and chlordanes": Response from Hardell and Eriksson
(
- Contribution to journal › Letter
-
Mark
Anthracycline-based chemotherapy as primary treatment for intravascular lymphoma
(
- Contribution to journal › Article
- 2003
-
Mark
Expression of p53, PCNA, Ki-67 and bcl-2 in relation to risk factors in oral cancer - a molecular epidemiological study.
(
- Contribution to journal › Article
-
Mark
Is the decline of the increasing incidence of non-Hodgkin lymphoma in Sweden and other countries a result of cancer preventive measures?
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Glutathione S-transferase genotype and p53 mutations in adenocarcinoma of the small intestine
(
- Contribution to journal › Article
-
Mark
Increased concentrations of polychlorinated biphenyls, hexachlorobenzene, and chlordanes in mothers of men with testicular cancer
(
- Contribution to journal › Article
- 2002
-
Mark
The importance of smoking and medical history for development of small bowel carcinoid tumor: a European population-based case-control study
(
- Contribution to journal › Article
-
Mark
Occupational risk factors for small bowel carcinoid tumor: A European population-based case-control study
(
- Contribution to journal › Article